NO179555C - Fremgangsmåte til fremstilling av terapeutisk aktive rebeccamycinanaloger - Google Patents

Fremgangsmåte til fremstilling av terapeutisk aktive rebeccamycinanaloger

Info

Publication number
NO179555C
NO179555C NO910855A NO910855A NO179555C NO 179555 C NO179555 C NO 179555C NO 910855 A NO910855 A NO 910855A NO 910855 A NO910855 A NO 910855A NO 179555 C NO179555 C NO 179555C
Authority
NO
Norway
Prior art keywords
preparation
rebeccamycin
therapeutically active
analogs
rebeccamycin analogs
Prior art date
Application number
NO910855A
Other languages
English (en)
Norwegian (no)
Other versions
NO179555B (no
NO910855L (no
NO910855D0 (no
Inventor
Kin Sing Lam
Daniel R Schroeder
Jacqueline Mattei
Salvatore Forenza
James A Matson
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO910855D0 publication Critical patent/NO910855D0/no
Publication of NO910855L publication Critical patent/NO910855L/no
Publication of NO179555B publication Critical patent/NO179555B/no
Publication of NO179555C publication Critical patent/NO179555C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Ceramic Products (AREA)
NO910855A 1990-03-06 1991-03-05 Fremgangsmåte til fremstilling av terapeutisk aktive rebeccamycinanaloger NO179555C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48943090A 1990-03-06 1990-03-06
US64875191A 1991-02-05 1991-02-05

Publications (4)

Publication Number Publication Date
NO910855D0 NO910855D0 (no) 1991-03-05
NO910855L NO910855L (no) 1991-09-09
NO179555B NO179555B (no) 1996-07-22
NO179555C true NO179555C (no) 1996-10-30

Family

ID=27049711

Family Applications (1)

Application Number Title Priority Date Filing Date
NO910855A NO179555C (no) 1990-03-06 1991-03-05 Fremgangsmåte til fremstilling av terapeutisk aktive rebeccamycinanaloger

Country Status (22)

Country Link
US (1) US5468849A (da)
EP (1) EP0450327B1 (da)
JP (1) JPH0780899B2 (da)
KR (1) KR940005657B1 (da)
AT (1) ATE138926T1 (da)
AU (1) AU623050B2 (da)
CY (1) CY1941A (da)
CZ (1) CZ279307B6 (da)
DE (1) DE69119964T2 (da)
DK (1) DK0450327T3 (da)
ES (1) ES2088439T3 (da)
FI (1) FI102376B1 (da)
GR (1) GR3020163T3 (da)
HK (1) HK181496A (da)
HU (1) HU211055B (da)
IE (1) IE910737A1 (da)
IL (1) IL97233A (da)
NO (1) NO179555C (da)
PT (1) PT96943B (da)
SG (1) SG63555A1 (da)
TW (1) TW232698B (da)
YU (1) YU39391A (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589365A (en) * 1991-11-29 1996-12-31 Banyu Pharmaceutical Co., Ltd. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
US5437996A (en) * 1992-11-24 1995-08-01 Banyu Pharmaceutical Co., Ltd. Microtetraspora strain for preparation of indolopyrrolocarbazole derivatives
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
EP0630242B1 (en) * 1992-03-20 1999-01-20 The Wellcome Foundation Limited Further indole derivatives with antiviral activity
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
WO1995034663A1 (fr) * 1994-06-13 1995-12-21 Banyu Pharmaceutical Co., Ltd. Gene codant la glycosyl-transferase et utilisation de ce gene
AU710669B2 (en) * 1996-08-22 1999-09-23 Bristol-Myers Squibb Company Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
US6653290B2 (en) 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
YU74103A (sh) * 2001-03-22 2006-05-25 Bristol-Myers Squibb Company Topoizomeraza i selektivni citotoksični šećerni derivati indolopirolokarbazola

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552842A (en) * 1983-01-28 1985-11-12 Bristol-Myers Company Process for producing rebeccamycin
US4487925A (en) 1983-01-28 1984-12-11 Bristol-Myers Company Rebeccamycin and process for its preparation
US4524145A (en) * 1984-09-04 1985-06-18 Bristol-Myers Company 4'-Deschlororebeccamycin pharmaceutical composition and method of use
US4567143A (en) * 1984-09-04 1986-01-28 Bristol-Myers Company Process for preparing 4'-deschlororebeccamycin
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
US4808613A (en) * 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition

Also Published As

Publication number Publication date
AU623050B2 (en) 1992-04-30
FI911047A0 (fi) 1991-03-01
IE910737A1 (en) 1991-09-11
EP0450327A1 (en) 1991-10-09
FI102376B (fi) 1998-11-30
EP0450327B1 (en) 1996-06-05
KR940005657B1 (ko) 1994-06-22
DK0450327T3 (da) 1996-06-24
FI102376B1 (fi) 1998-11-30
YU39391A (sh) 1994-01-20
TW232698B (da) 1994-10-21
KR910016934A (ko) 1991-11-05
PT96943B (pt) 1998-07-31
NO179555B (no) 1996-07-22
CY1941A (en) 1997-05-16
SG63555A1 (en) 1999-03-30
JPH0789981A (ja) 1995-04-04
NO910855L (no) 1991-09-09
FI911047A (fi) 1991-09-07
HUT61601A (en) 1993-01-28
IL97233A (en) 1995-03-30
CS9100586A2 (en) 1991-10-15
ATE138926T1 (de) 1996-06-15
DE69119964T2 (de) 1997-02-06
HK181496A (en) 1996-10-04
US5468849A (en) 1995-11-21
CZ279307B6 (cs) 1995-04-12
IL97233A0 (en) 1992-05-25
ES2088439T3 (es) 1996-08-16
HU910716D0 (en) 1991-09-30
GR3020163T3 (en) 1996-09-30
DE69119964D1 (de) 1996-07-11
PT96943A (pt) 1991-10-31
NO910855D0 (no) 1991-03-05
HU211055B (en) 1995-10-30
JPH0780899B2 (ja) 1995-08-30
AU7261691A (en) 1991-09-12

Similar Documents

Publication Publication Date Title
DE69303879D1 (de) Verfahren zur Herstellung von N4-acyl-5'-desoxy-5-fluorocytidinderivate
NO20083728L (no) Analogifremgangsmate for fremstilling av et terapeutisk aktivt nukleosid
NO179555C (no) Fremgangsmåte til fremstilling av terapeutisk aktive rebeccamycinanaloger
ATE42303T1 (de) Herstellung von nukleosiden.
LU91498I2 (fr) Etanercept et ses dérivés pharmaceutiquement acceptables.
MD1155C2 (ro) Procedee diastereoselective de obţinere a cis-nucleozidelor, analogiilor şi derivaţilor optic activi, compuşi intermediari şi procedee de obţinere a lor
FI945323A (fi) 5-metyyliuridiinimenetelmä 2',3'-didehydro-3'-deoksitymidiinin (d4T) laajamittaista valmistusta varten
PT74246A (en) Process for preparing hbsag
ES441788A1 (es) Procedimiento para la obtencion de derivadas de depeptidos.
FR2734171B1 (fr) Procede de production d'oxygene sous pression par adsorption
CA2037596A1 (en) Rebeccamycin analog by bromide precursor feeding
CA2037783A1 (en) Rebeccamycin analogs by tryptophan analogs feeding
NO974512D0 (no) Fremgangsmåte for syntese av nukleosid-analoger
EP0133550A3 (en) Process for producing arphamenine in high yield
JPS5234984A (en) Production of adenine derivatives by fermentation process
FI882979A (fi) Mikrobiologinen menetelmä 4'-13(S)-dihydro-4'-jodidoksorubisiinin valmistamiseksi